Roche Holding AG

Roche was founded in Switzerland in 1896 as one of the first companies specifically set up to manufacture scientifically researched pharmaceuticals. Already at an early stage the company expanded to other countries such as Italy and Germany.Ever since, Roche has been harnessing innovation and novel technologies to evolve the practice of medicine and help patients live longer, better lives. Today, we are the world’s largest biotechnology company and the global leader in in-vitro diagnostics, dedicated to tackling healthcare challenges that place the greatest strain on patients, families, communities and healthcare systems.Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).